Protein kinase C is required for neutrophil migration as is the regulatory molecule calmodulin. The actin binding protein Myristoylated Alanine‐Rich C‐kinase Substrate (MARCKS), which is phosphorylated by PKC and binds calmodulin, is a potential point of convergence of these two regulatory mechanisms. Stimulation of neutrophils with the chemoattractant peptide fMLF results in rapid MARCKS phosphorylation and dissociation from the cell membrane. The hypothesis that MARCKS has a role in the regulation of neutrophil migration was tested using a myristoylated peptide corresponding to the first 24 amino acids of the MARCKS aminoterminus (MANS peptide). Treatment of isolated human neutrophils with MANS (50 μM) significantly inhibited their migration and beta 2 integrin dependent adhesion in response to fMLF, IL8, or LTB 4 . A missense peptide (RNS peptide) did not affect migration or adhesion. MANS significantly reduced F‐actin content in neutrophils 30s after fMLF stimulation, although the peptide did not alter the ability of cells to organize the actin cytoskeleton or spread. MANS did not alter fMLF stimulated increase in surface expression of beta 2 integrins. Our data suggest that MARCKS, via its myristoylated aminoterminus, is a key regulator of neutrophil migration and adhesion. Supported by NIH R37 HL36982 and the NC State Center for Comparative Medicine and Translational Research.
Abstract Vasodilator-stimulated phosphoprotein (VASP) is a cAMP-dependent protein kinase A (PKA) substrate, which links cellular signaling to cytoskeletal organization and cellular movement. VASP is phosphorylated by PKA on serine 157 (Ser 157), which is required for VASP function in platelet adhesion and fibroblast motility. Our hypothesis is that PKA regulates neutrophil migration through VASP Ser 157 phosphorylation. The objective of this study was to characterize VASP Ser 157 phosphorylation in chemoattractant-stimulated neutrophils. fMLF, IL-8, leukotriene B4, or platelet-activating factor stimulation resulted in an initial increase in VASP Ser 157 phosphorylation, which was maximal by 30 s and was followed by a return to baseline Ser 157 phosphorylation by 10 min. In contrast, stimulation with the nonchemoattractant, proinflammatory cytokine TNF-α did not affect Ser 157 phosphorylation. The kinetics of fMLF-induced VASP Ser 157 phosphorylation levels closely matched the kinetics of the fold-change in F-actin levels in fMLF-stimulated neutrophils. fMLF-induced Ser 157 phosphorylation was abolished by pretreatment with the PKA inhibitor H89 and the adenylyl cyclase inhibitor SQ22536. In contrast, fMLF-induced Ser 157 phosphorylation was unaffected by the PKC inhibitors calphostin and staurosporine, the PKG inhibitors Rp-8-pCPT-cGMP and KT5823, and the calmodulin-dependent protein kinase II inhibitor KN-62. Inhibition of adhesion with EDTA or the anti-β2-integrin antibody IB4 did not alter fMLF-induced VASP phosphorylation or dephosphorylation. These data show that chemoattractant stimulation of human neutrophils induces a rapid and transient PKA-dependent VASP Ser 157 phosphorylation. Adhesion does not appear to be an important regulator of the state of VASP Ser 157 phosphorylation in chemoattractant-stimulated neutrophils.